Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
81626764 | 8162676 | 4 | F | 20160810 | 20110929 | 20160818 | EXP | US-ASTRAZENECA-2011SE56852 | ASTRAZENECA | 76.00 | YR | M | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
81626764 | 8162676 | 1 | PS | RHINOCORT | BUDESONIDE | 1 | Nasal | ONE SPRAY PER NOSTRIL DAILY | U | 20746 | NASAL SPRAY | ||||||||
81626764 | 8162676 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | ||||||||||
81626764 | 8162676 | 3 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | U | 0 | MODIFIED-RELEASE TABLET | |||||||||
81626764 | 8162676 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5.0MG UNKNOWN | 0 | 5 | MG | TABLET |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
81626764 | 8162676 | HO |
81626764 | 8162676 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
81626764 | 8162676 | Cardiac disorder | |
81626764 | 8162676 | Drug ineffective | |
81626764 | 8162676 | Dyspnoea | |
81626764 | 8162676 | Exostosis | |
81626764 | 8162676 | Intentional product misuse | |
81626764 | 8162676 | Malaise | |
81626764 | 8162676 | Poor peripheral circulation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |